2,4-Dichlorophenoxyacetic Acid From India: Final Affirmative Countervailing Duty Determination

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Commerce International Trade Administration [C-533-923] AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The U.S. Department of Commerce (Commerce) determines that countervailable subsidies are being provided to producers and exporters of 2,4-dichlorophenoxyacetic Acid (2,4-D) from India. The period of investigation is January 1, 2023, through December 31, 2023. DATES: Applicable April 7, 2025. FOR FURTHER INFORMATION CONTACT: Harrison Tanchuck or George McMahon, AD/CVD Operations, Office VI, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482-7421 or (202) 482-1167, respectively. SUPPLEMENTARY INFORMATION: Background On September 13, 2024, Commerce published its Preliminary Determination in the in the Federal Register and aligned this countervailing duty (CVD) investigation with the final determination in the less-than-fair-value investigation of 2,4-D from India, in accordance with in accordance with section 705(a)(1) of the Tariff Act of 1930, as amended (the Act), and 19 CFR 351.210(b)(4) , Commerce aligned the final CVD determination with the final antidumping duty determination. [ 1 ] On October 31, 2024, Commerce issued its Post-Preliminary Analysis. [ 2 ] For a summary of the events that occurred since the Preliminary Determination, see the Issues and Decision Memorandum. [ 3 ] The Issues…